MME and non-small cell lung carcinoma: Prior evidence also suggests that cells expressing these markers may have tumour-promoting and immunosuppressive effects; CD10 expression in tumour stroma and in CAFs has previously been associated with tumour stemness and chemoresistance in non-small cell lung cancer as well as with high tumour grades and poor patient survival18,43–45.